Madrid, Spain

Jesus Andres Blas

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jesus Andres Blas. Retrieved from https://idiyas.com/inventor/jesus-andres-blas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Jesus Andres Blas from Madrid

Introduction

Jesus Andres Blas is a prominent inventor based in Madrid, Spain. With a keen focus on biochemistry, he has made significant contributions to the field through his innovative work at Eli Lilly and Company. He holds one patent, which reflects his commitment to advancing medical science.

Latest Patents

Blas is credited with a noteworthy patent involving kinase inhibitors. The present invention provides kinase inhibitors of Formula I, which hold potential therapeutic applications. This patent is a testament to his expertise in the area of medicinal chemistry and his dedication to developing solutions for unmet medical needs.

Career Highlights

Throughout his career, Jesus Andres Blas has worked tirelessly at Eli Lilly and Company, where he has honed his skills and expanded his knowledge in drug development. His industrious nature and innovative mindset have positioned him as a vital member of the research community within the organization.

Collaborations

In his journey, Blas has collaborated with esteemed colleagues such as Tiechao Li and Mark Andrew Pobanz. These partnerships not only enrich his research but also enhance the collective knowledge and expertise within the team, leading to more robust innovative outcomes.

Conclusion

Jesus Andres Blas stands out as an influential inventor in the field of biochemistry. His work, particularly in kinase inhibitors, showcases his dedication to innovation and collaboration. As he continues his career at Eli Lilly and Company, he is sure to make further significant contributions to science and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…